Dr. Hamid B discusses long-hauler syndrome and MIS-C following COVID-19 infection in children. Talking about his experience studying COVID-19 disease in young children, he says, “This is one of the other primary reasons to consider vaccination in children … not just because they got a disease for three, four, five days, but it can affect them for months, and potentially even years down the line due to … the post-acute effects of this viral syndrome.” For information about COVID-19, visit http://COVIDVaccineAnswers.org.

Video created by and for the Vaccine Education Center at Children’s Hospital of Philadelphia. ©2021. All rights reserved.

The Vaccine Education Center at Children’s Hospital of Philadelphia (VEC at CHOP) is composed of scientists, physicians, mothers, and fathers devoted to the study and prevention of infectious diseases. The Center was launched in October 2000 to provide accurate, comprehensive and up-to-date information about vaccines and the diseases they prevent.

For information about vaccines and vaccine safety, visit http://vaccine.chop.edu.

“If you have any questions or concerns about your child’s health, please contact your child’s healthcare provider. This video is intended only to provide general educational information. You should not rely on this information as medical advice or treatment. Do not attempt anything you may see in this video without first consulting with your healthcare provider. If a CHOP provider did not instruct you to view this video, please do not use this video without first discussing with your own healthcare provider. This video is not intended to create a doctor-patient relationship between you and CHOP. CHOP is not responsible for any outcomes you or your child might experience from your use of this video. This video is provided “AS IS” with no warranties or representations. The Terms of Use and Privacy Policy on CHOP.edu apply to all uses of and access to this video. This video is copyright of CHOP. All rights reserved.”
Video Rating: / 5

Share this page:

Learn about cardiovascular disease from the heart experts, including risk factors, prevention, and symptoms.

About the Edith and Benson Ford Heart & Vascular Institute

The Edith and Benson Ford Heart & Vascular Institute is one of Henry Ford Health System’s busiest Centers of Excellence treating more than 114,000 patients each year. It is ranked among the top cardiac centers in the nation by US News & World Report. The program is one of only two in Michigan for advanced heart failure treatment options and one of the few programs in the country offering robotically assisted laparoscopic aortic surgery. For more on the Heart and Vascular Institute, visit https://www.henryford.com/services/cardiology

About Henry Ford Health System

Henry Ford Health System (HFHS) is a Michigan not-for-profit corporation governed by a 22-member Board of Trustees. Advisory and affiliate boards comprising 129 Trustee volunteer leaders provide vital links to the communities served by the System. HFHS is managed by Chief Executive Officer Nancy M. Schlichting.

HFHS is one of the nation’s leading comprehensive, integrated health systems. It provides health insurance and health care delivery, including acute, specialty, primary and preventive care services backed by excellence in research and education. For more information, visit http://www.henryford.com

Share this page: